Abstract
Although a vaccine against SARS-CoV-2 Omicron-XBB.1.5 variant is available worldwide and recent infection is protective, the lack of recorded infection data highlights the need to assess variant-specific antibody neutralization levels. We analyzed IgG levels against receptor-binding domain–specific SARS-CoV-2 ancestral strain as a correlate for high neutralizing titers against XBB variants.
Original language | English |
---|---|
Pages (from-to) | 1050-1052 |
Number of pages | 3 |
Journal | Emerging Infectious Diseases |
Volume | 30 |
Issue number | 5 |
DOIs | |
State | Published - 1 May 2024 |
ASJC Scopus subject areas
- Epidemiology
- Microbiology (medical)
- Infectious Diseases